# Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

> **NCT01281124** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 1 (actual)

## Conditions studied

- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Non-Small Cell Cancer AJCC v7

## Interventions

- **DRUG:** Azacitidine
- **OTHER:** Diagnostic Laboratory Biomarker Analysis
- **OTHER:** Pharmacological Study

## Key facts

- **NCT ID:** NCT01281124
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-12
- **Primary completion:** 2011-04-15
- **Final completion:** 2012-09-12
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01281124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01281124, "Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01281124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*